"Lymphocyte to monocyte ratio" trang 1 - tải miễn phí từ tailieunhanh
Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma

Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma
11    48    1
Combination of preoperative neutrophillymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: A superior prognostic factor of endometrial cancer

Combination of preoperative neutrophillymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: A superior prognostic factor of endometrial cancer
11    96    0
Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1–2 rectal cancer

Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1–2 rectal cancer
11    92    0
Prognostic value of the preoperative lymphocyte-to-monocyte ratio for survival after lung cancer surgery

Prognostic value of the preoperative lymphocyte-to-monocyte ratio for survival after lung cancer surgery
8    29    1
Neutrophil-lymphocyte ratio associated with poor prognosis in oral cancer: A retrospective study

Neutrophil-lymphocyte ratio associated with poor prognosis in oral cancer: A retrospective study
9    62    1
The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer

The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer
8    63    1
Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma

Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma
9    93    0
Predictive value of lymphocyte-tomonocyte ratio in the preoperative setting for progression of patients with breast cancer

Predictive value of lymphocyte-tomonocyte ratio in the preoperative setting for progression of patients with breast cancer
9    32    1
Peripheral blood lymphocyte/monocyte ratio at the time of first relapse predicts outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma

Peripheral blood lymphocyte/monocyte ratio at the time of first relapse predicts outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma
11    50    1
The role of lymphocyte-monocyte ratio on axial spondyloarthritis diagnosis and sacroiliitis staging

The role of lymphocyte-monocyte ratio on axial spondyloarthritis diagnosis and sacroiliitis staging
9    40    1
Association of pre-treatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiation

Association of pre-treatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiation
10    6    1
Predictive value of lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) in patients with oesophageal cancer undergoing concurrent chemoradiotherapy

Predictive value of lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) in patients with oesophageal cancer undergoing concurrent chemoradiotherapy
9    75    0
Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitors

Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitors
7    75    1
Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment

Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment
11    35    1
The prognostic and predictive value of tumor-infiltrating lymphocytes and hematologic parameters in patients with breast cancer

The prognostic and predictive value of tumor-infiltrating lymphocytes and hematologic parameters in patients with breast cancer
9    30    1
Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocytemonocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy

Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocytemonocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy
13    18    1
Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: A meta-analysis

Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: A meta-analysis
12    83    0
Long-term outcomes and significance of preoperative lymphocyte-to-monocyte ratio as a prognostic indicator in patients with invasive pancreatic neoplasms after repeat pancreatectomy

Long-term outcomes and significance of preoperative lymphocyte-to-monocyte ratio as a prognostic indicator in patients with invasive pancreatic neoplasms after repeat pancreatectomy
9    38    1
Prognostic utility of systemic inflammatory markers and chronic hepatitis C virus infection status in hepatocellular carcinoma patients treated with local ablation

Prognostic utility of systemic inflammatory markers and chronic hepatitis C virus infection status in hepatocellular carcinoma patients treated with local ablation
14    18    1